Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Anti-glycan antibodies are an abundant subpopulation of serum antibodies with critical functions in many immune processes. Changes in the levels of these antibodies can occur with the onset of disease, exposure to pathogens, or vaccination. As a result, there has been significant interest in exploiting anti-glycan antibodies as biomarkers for many diseases. Serum contains a mixture of anti-glycan antibodies that can recognize the same antigen, and competition for binding can potentially influence the detection of antibody subpopulations that are more relevant to disease processes. The most abundant antibody isotypes in serum are IgG, IgM, and IgA, but little is known regarding how these different isotypes compete for the same glycan antigen. In this study, we developed a multiplexed glycan microarray assay and applied it to evaluate how different isotypes of anti-glycan antibodies (IgA, IgG, and IgM) compete for printed glycan antigens. While IgG and IgA antibodies typically outcompete IgM for peptide or protein antigens, we found that IgM outcompete IgG and IgA for many glycan antigens. To illustrate the importance of this effect, we provide evidence that IgM competition can account for the unexpected observation that IgG of certain antigen specificities appear to be preferentially transported from mothers to fetuses. We demonstrate that IgM in maternal sera compete with IgG resulting in lower than expected IgG signals. Since cord blood contains very low levels of IgM, competition only affects maternal IgG signals, making it appear as though certain IgG antibodies are higher in cord blood than matched maternal blood. Taken together, the results highlight the importance of competition for studies involving anti-glycan antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474 · cited 1×
“Due to the affinity maturation and class switching processes, IgG and IgA antibodies typically have substantially higher affinities than IgM antibodies [18,19].”
BackgroundProtein-glycan interactions in the control of innate and adaptive immune responses
van Kooyk, Y., & Rabinovich, G. A. (2008) · Nature Immunology · doi:10.1038/ni.f.203 · Cited by 807
Peripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Molecular Mechanism of Class Switch Recombination: Linkage with Somatic Hypermutation
Honjo, T., Kinoshita, K., & Muramatsu, M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.090501.112049 · Cited by 598 · cited 1×
“Due to the affinity maturation and class switching processes, IgG and IgA antibodies typically have substantially higher affinities than IgM antibodies [18,19].”
BackgroundWatkins, W. M. (1966) · Science · doi:10.1126/science.152.3719.172 · Cited by 540
Glycan Microarrays for Decoding the Glycome
Rillahan, C. D., & Paulson, J. C. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061809-152236 · Cited by 428
Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy
Springer, G. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050144 · Cited by 426
The α‐gal epitope and the anti‐Gal antibody in xenotransplantation and in cancer immunotherapy
Galili, U. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01366.x · Cited by 336
Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport
KOHLER, P. F., & FARR, R. S. (1966) · Nature · doi:10.1038/2101070a0 · Cited by 325
High-Mannose Glycans are Elevated during Breast Cancer Progression
de Leoz, M. L. A., Young, L. J. T., An, H. J., Kronewitter, S. R., Kim, J., Miyamoto, S., Borowsky, A. D., Chew, H. K., & Lebrilla, C. B. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002717 · Cited by 320
Research works printed but not linked: 1
- CT Campbell, 2010, Construction and use of glycan microarrays, Current Protocols in Chemical Biology, 2, 37, 10.1002/9780470559277.ch090228 · DOI
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Indeed a significant fraction of circulating Ig found in normal humans may be directed against foreign glycan antigens (971) (972) (973) .”
BackgroundMatricardi, P. M., Dal Negro, R. W., & Nisini, R. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13271 · Cited by 211
Glycan Arrays: From Basic Biochemical Research to Bioanalytical and Biomedical Applications
Geissner, A., & Seeberger, P. H. (2016) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071015-041641 · Cited by 85
Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum
Muthana, S. M., & Gildersleeve, J. C. (2016) · Scientific Reports · doi:10.1038/srep19509 · Cited by 68
“The anti-IgG reagent detects all IgG subclasses, and signals for IgM and IgG are roughly comparable on micrograms/mL level 45 .”
Self-citationWhole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins
Xia, L., Schrump, D. S., & Gildersleeve, J. C. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.10.012 · Cited by 49
Self-citationAnti-glycan antibodies: roles in human disease
Temme, J. S., Butler, D. L., & Gildersleeve, J. C. (2021) · Biochemical Journal · doi:10.1042/bcj20200610 · Cited by 48
Self-citationBentall, A., Jeyakanthan, M., Braitch, M. K., Cairo, C. W., Lowary, T. L., Maier, S., Halpin, A., Motyka, B., Zou, L., West, L. J., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16712 · Cited by 43
Durbin, S. V., Wright, W. S., & Gildersleeve, J. C. (2018) · ACS Omega · doi:10.1021/acsomega.8b02238 · Cited by 32
Self-citationZhang, Q., Cong, R., Hu, M., Zhu, Y., & Yang, X. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/9459156 · Cited by 30
“Antibodies IgA, IgM, and IgG in sera were measured by ELISA according to the report [26].”
BackgroundInfluentialSerum antibody screening using glycan arrays
Marglous, S., Brown, C. E., Padler‐Karavani, V., Cummings, R. D., & Gildersleeve, J. C. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00693j · Cited by 32
Self-citationAbnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients
Butler, D. L., Imberti, L., Quaresima, V., Fiorini, C., Barnett, J., Chauvin, S. D., Cheng, X., Danielson, J. J., Dobbs, K., Garabedian, E., et al. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac062 · Cited by 30
Self-citationHow glycobiology can help us treat and beat the COVID-19 pandemic
Lardone, R. D., Garay, Y. C., Parodi, P., de la Fuente, S., Angeloni, G., Bravo, E. O., Schmider, A. K., & Irazoqui, F. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100375 · Cited by 27
“Natural anti-glycan antibodies are relevant soluble components of innate immunity against viral infections, where the IgM isotype has a central role but IgG and IgA are also are relevant (49, 50).”
Bosqui, L. R., Gonçalves, A. L. R., Gonçalves-Pires, M. D. R. F., Custódio, L. A., de Menezes, M. C. N. D., Murad, V. A., de Paula, F. M., Pavanelli, W. R., Costa, I. C., Costa‐Cruz, J. M., et al. (2015) · Acta Tropica · doi:10.1016/j.actatropica.2015.07.026 · Cited by 25
Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications
Tikhonov, A. A., Smoldovskaya, O., Feyzkhanova, G., Кушлинский, Н. Е., & Rubina, A. Y. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-1161 · Cited by 23
“an increase in the levels of IgG and/or IgA associated with it [66].”
BackgroundABO blood type correlates with survival on prostate cancer vaccine therapy
Muthana, S. M., Gulley, J. L., Hodge, J. W., Schlom, J., & Gildersleeve, J. C. (2015) · Oncotarget · doi:10.18632/oncotarget.4993 · Cited by 21
Self-citationShukla, S., Dorand, R. D., Myers, J., Woods, S. E., Gulati, N. M., Stewart, P. L., Commandeur, U., Huang, A. Y.-C., & Steinmetz, N. F. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00060 · Cited by 23
Perry, H. E., Bovin, N. V., & Henry, S. M. (2019) · Transfusion · doi:10.1111/trf.15247 · Cited by 21
Ben‐Arye, S. L., Schneider, C., Yu, H., Bashir, S., Chen, X., von Gunten, S., & Padler‐Karavani, V. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00273 · Cited by 24
Zhang, Y., Niu, J., Zhang, S., Si, X., Bian, T., Wu, H., Li, D., Sun, Y., Jia, J., Xin, E., et al. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2086990 · Cited by 20
“DTH occurs when DNFB solution is applied to the skin again 4-7 days later (Muthana et al. 2015).”
BackgroundSelf-citationTaghavian, O., Jain, A., Joyner, C. J., Ketchum, S., Nakajima, R., Jasinskas, A., Liang, L., Fong, R., King, C. L., Greenhouse, B., et al. (2017) · PROTEOMICS · doi:10.1002/pmic.201700277 · Cited by 19
O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy
Novák, J., King, R. G., Yother, J., Renfrow, M. B., & Green, T. J. (2024) · Glycobiology · doi:10.1093/glycob/cwae060 · Cited by 23
Dias, J. T., Lama, L., Gantelius, J., & Svahn, H. A. (2016) · Nanoscale · doi:10.1039/c5nr09207h · Cited by 19
“Muthana et al. 15 has shown that removing interfering molecules with a preceding purification step improved detection.”
BackgroundAntibodies against aberrant glycans as cancer biomarkers
Blšáková, A., Květoň, F., Kasák, P., & Tkáč, J. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1687295 · Cited by 14
“the interface at a density matching their natural density in living cells [52,98], a feature important for effective binding of AGA.”
BackgroundStructure–function relationships of protein–lipopeptide complexes and influence on immunogenicity
Wijayadikusumah, A. R., Sullivan, L. C., Jackson, D. C., & Chua, B. Y. L. (2017) · Amino Acids · doi:10.1007/s00726-017-2466-6 · Cited by 12
Květoň, F., Blšáková, A., Hushegyi, A., Damborský, P., Blixt, O., Jansson, B., & Tkáč, J. (2017) · Langmuir · doi:10.1021/acs.langmuir.6b04021 · Cited by 11
Mader, K., & Dustin, L. B. (2024) · Antibodies · doi:10.3390/antib13020028 · Cited by 13
Coz, C. L., Trofa, M., Butler, D. L., Yoon, S., Tian, T., Reid, W., Cabrera, E. C., Knox, A. V. C., Khanna, C., Sullivan, K. E., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.04.018 · Cited by 7
Self-citationPoly-L-Lysine-Based αGal-Glycoconjugates for Treating Anti-αGal IgE-Mediated Diseases
Olivera‐Ardid, S., Bello‐Gil, D., Tuzikov, A. B., Araújo, R. N., Ferrero-Alves, Y., Figueroa, B. E. G., Labrador‐Horrillo, M., García-Pérez, A. L., Bovin, N. V., & Máñez, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873019 · Cited by 6
“However, IgM is a pentamer with ten Fab capable of a multivalent binding (76).”
BackgroundPruksaphon, K., Khamto, N., Amsri, A., Wagatsuma, M., Nosanchuk, J. D., Higuchi, Y., & Youngchim, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1666690 · Cited by 5
“This limited af fi nity is inherently linked to the TI nature of most glycan antigens, which fail to induce germinal center reactions required for high-af fi nity B-cell selection and clonal expansion (115, 116).”
New, J. S., Fucile, C., Callahan, A. R., Burke, J. N., Davis, R. S., Duck, W. L., Rosenberg, A. F., Kearney, J. F., & King, R. G. (2026) · Immunity · doi:10.1016/j.immuni.2026.02.001 · Cited by 7
Multiplex analysis of ovarian cancer patients using glycan microarray
Pokrovsky, V. S., Qoura, L. A., Tikhonov, A. A., Rubina, A. Y., & Kushlinskii, N. E. (2025) · Analytical Biochemistry · doi:10.1016/j.ab.2025.115806 · Cited by 5
Martinino, A., Smith, T. J., Elmore, Z. C., Yoon, J., Ladowski, J. M., Schiliró, D., Hull, J. A., Schwalb, A., Hu, M., Spangler, R. D., et al. (2025) · Xenotransplantation · doi:10.1111/xen.70023 · Cited by 5
RetractedChoi, H. R., Piao, H., Atriardi, S. R., Kang, I., Chang, T. K., Kim, S., Jang, J. Y., Lee, G.-M., Jung, K. C., Mardhiyah, H., et al. (2026) · Blood · doi:10.1182/blood.2025030660 · Cited by 3
Rodrigues, J. P., & de Andrade, H. F. (2022) · Journal of Fluorescence · doi:10.1007/s10895-022-02892-8 · Cited by 3
“The final arrange of TFISA uses a higher dilution of sera (1/200) in order to supply a vast excess of antigen in the reaction, for avoiding IgG blocking of antigens, due their high prevalence in serum [11].”
Methodde Carvalho, C. A., Hiramoto, R. M., Meireles, L. R., & de Andrade, H. F. (2021) · Parasitology · doi:10.1017/s0031182021001189 · Cited by 3
Hafeez, S., & Zaidi, N. U. S. S. (2024) · Antibodies · doi:10.3390/antib13030064 · Cited by 2
Martinino, A., Li, Z., Smith, T. J., Schiliró, D., Elmore, Z. C., Yoon, J., Fatzaun, E., Belloni, R., Ferrara, V. Z., Tunbridge, M. J., et al. (2025) · American Journal of Transplantation · doi:10.1016/j.ajt.2025.10.007 · Cited by 2
Kappler, K., Restin, T., Lasanajak, Y., Smith, D. F., Bassler, D., & Hennet, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573629 · Cited by 2
“On the contrary, the cord blood levels of IgG to xenoantigens, such as α-rhamnose and the Forssman antigen, and to bacterial lipopolysaccharides from Escherichia coli O16, O6, and O111 have been shown to be at least as high as in matched maternal samples (21, 22).”
ResultBerre, M. L., Paulovčáková, T., Veríssimo, C. D. M., Doyle, S., Dalton, J. P., Masterson, C. H., Martínez, E. R., Walsh, L., Gormley, C., Laffey, J. G., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283537 · Cited by 2
“Competition between IgG, IgA, and IgM isotypes for glycan antigen binding has also been previously reported [43], as well as competitive inhibition between IgG1 and IgG2 subclasses [44].”
Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours
Semwal, S., Boukherroub, R., Savvides, S. N., & Bouckaert, J. M. J. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210728103524 · Cited by 4
“Certain studies also show that IgM can bind very tightly to the glycan antigens with affinities in the sub- nanomolar range, making them better binders to glycan epitopes when compared to IgGs [129, 130].”
BackgroundInfluentialLossos, C., Nadji, M., Lossos, I. S., & Chapman, J. R. (2022) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000001091 · Cited by 1
Some Human Anti-Glycan Antibodies Lack the Ability to Activate the Complement System
Shilova, N. V., Nokel, A. Y., Lipatnikov, A., Khasbiullina, N. R., Knirel, Y. A., Baidakova, L. K., Tuzikov, A. B., Khaidukov, S. V., Obukhova, P. S., Henry, S. M., et al. (2024) · Antibodies · doi:10.3390/antib13040105 · Cited by 1
Structures of proteinase 3 and the CD177 receptor complex reveal a major autoantibody epitope
Zheng, C., Joha, J., Carrasquero, M., Omari, K. E., Lowe, E. D., Dubey, S., Draper, S. J., Chang, Y.-C., Lin, H., Salama, A. D., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00716-5 · Cited by 1
Applıcatıon of PLS-SEM ın assessment of the effect of anımal welfare
SARAÇOĞLU, M., Yurtseven, S., & Yalçın, H. (2025) · Medycyna Weterynaryjna · doi:10.21521/mw.7006 · Cited by 1
Efficient separation of IgG from IgM antibodies via conjugated surfactant micelles
Withanage, T. J., Krieger, R., Wachtel, E. J., & Patchornik, G. (2023) · Journal of Chromatography B · doi:10.1016/j.jchromb.2023.123805 · Cited by 1
Development of Novel Carbohydrate Blood Group Related Kodecyte Assays
Perry, E. H. (2019) · Tuwhera (Auckland University of Technology) · Cited by 1
Paulovičová, E., & Hrubiško, M. (2021) · Immunobiology · doi:10.1016/j.imbio.2021.152154 · Cited by 1
An IgM Cleaving Enzyme for Clearance of Anti‐Pig Xenoreactive Antibodies in a Nonhuman Primate Model
Martinino, A., Smith, T. J., Elmore, Z. C., Yoon, J., Ladowski, J. M., Schiliró, D., Hull, J. A., Schwalb, A., Hu, M., Spangler, R. D., et al. (2025) · Xenotransplantation · doi:10.1111/xen.70015 · Cited by 3
“In xenotransplantation, IgM is considered the main immunoglobulin isotype in the onset of antibody-mediated rejection [36] potentially via more efficiently activating complement [37, 38] and its relative abundance over IgG [16].”
Immunological Foundations of the Green, Resilient, Electric, and AI-Driven Transport (GREAT) System
Zhang, J. (2026) · Urban sustainability · doi:10.1007/978-981-95-5393-8_4
Tanunliong, G., Márquez, A. C., Krajden, M., Morshed, M. G., Jassem, A. N., & Sekirov, I. (2026) · Discover Viruses. · doi:10.1007/s44370-026-00036-1 · Cited by 1
Minimal structural glyco-epitope for antibody recognition
Robakiewicz, S. (2020) · theses.fr (ABES) · doi:10.70675/72508b78zf24bz46f6zaf89zb1d4e7428c9d
Athanasiadou, A., Kroos, S., van de Wetering, R., Schopmeijer, R., van der Keur, C., Eikmans, M., Meijer, C., Rantapää‐Dahlqvist, S., Toes, R. E. M., Slot, L. M., et al. (2026) · Arthritis & Rheumatology · doi:10.1002/art.70259
Multimodal precision diagnostics in clinical xenotransplantation
Meier, R. P. H., Morgand, E., Mezine, F., Mengel, M., Mangiola, M., Mohiuddin, M. M., Montgomery, R. A., & Loupy, A. (2026) · Nature · doi:10.1038/s41586-026-11096-0
“Together with genetically engineered pigs lacking key xenoantigens and expressing human complement and coagulation regulators, these combinations now support long-term xenograft survival in NHPs exceeding 2 years for kidneys and approaching 3 years for hearts 16,17,112,121,125,126 .”
Metadata
- Authors
- Muthana, S. M., Xia, L., Campbell, C. T., Zhang, Y., & Gildersleeve, J. C.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Gildersleeve, Jeffrey C.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-25
- Volume
- 10
- Issue
- 3
- Pages
- e0119298
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4373866
- OpenAlex
- W1977905136
- Cited by
- 53
- References
- 81
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 7 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 1 · 2017: 4 · 2016: 6 · 2015: 2
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Michigan State University
- National Institutes of Health (GM62116)
- College of Engineering, Michigan State University
- National Cancer Institute (GM62116)
- National Institute of General Medical Sciences (GM 62116, U54GM062116)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- anti-glycan antibodies, IgG, IgM, IgA, glycan microarrays, maternal-fetal antibody transfer, umbilical cord blood, biomarkers
- MeSH terms
- Antibody Affinity, Antigen-Antibody Reactions, Humans, Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, Polysaccharides, Biomarkers, Protein Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.